| Emily Nicole Johnson, APRN | |
|
750 E 29th St, Fremont, NE 68025-2384 | |
| (402) 753-2900 | |
| Not Available |
| Full Name | Emily Nicole Johnson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 750 E 29th St, Fremont, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003216888 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 111676 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily Nicole Johnson, APRN 750 E 29th St, Fremont, NE 68025-2384 Ph: (402) 753-2900 | Emily Nicole Johnson, APRN 750 E 29th St, Fremont, NE 68025-2384 Ph: (402) 753-2900 |
News Archive
A new paper by a team of researchers led by Zachary T. Schafer, Coleman Assistant Professor of Cancer Biology in the Department of Biological Sciences at the University of Notre Dame, offers important new insights into the role carcinoma-associated fibroblasts (CAFs) play in tumor biology.
Results of an international clinical study conducted in Europe and the US presented today at the International Liver CongressTM 2010, the Annual Meeting of the European Association for the Study of Liver in Vienna, Austria, have identified a genomic portrait able to predict recurrence in hepatocellular carcinoma (HCC), the fifth most common cancer in men.
The rates of death and health burdens associated with air pollution are borne unequally and inequitably by people of color and those with lower household income and educational attainment in Washington, D.C., according to a new study.
Researchers have found that a newly developed drug, which is aimed at a particular receptor involved in the development of blood vessels that sustain tumour growth, is active in patients with advanced cancers and, in some cases, has halted the progress of the disease. The drug, ACE-041, targets a different molecular pathway to other anti-angiogenesis drugs and may provide a new option to treat cancer.
The results of a recent national survey and benchmark study on employee healthcare benefits are now available. The 2013 Healthcare Benefits Trends Benchmark Study report provides insights into the adoption of new healthcare benefits, health exchanges, wellness, and related topics. The research was sponsored by the Healthcare Trends Institute, an educational platform for employers, consumers, and other healthcare benefits stakeholders.
› Verified 2 days ago
Claire Montoya, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 350 W 23rd St, Fremont, NE 68025 Phone: 402-721-7077 Fax: 402-721-7324 | |
Zachary Beerman, APRN (PMHNP) Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2560 N Healthy Way, Fremont, NE 68025 Phone: 402-941-7245 | |
Mrs. Kimberly D Mueller, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1240 E 23rd St, Fremont, NE 68025 Phone: 402-815-9741 | |
Amanda Nicole Esterling, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 220 E 22nd St, Fremont, NE 68025 Phone: 402-727-5500 Fax: 402-727-6047 | |
Megan Grote, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 450 E 23rd St, Fremont, NE 68025 Phone: 402-941-7030 Fax: 402-941-7032 | |
Amber Christine Juricek, DNP, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 680 E Fremont Medical Park Dr, Fremont, NE 68025 Phone: 402-727-1091 |